Market Tracker

10/23 5:51am ET

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

224.51
Data as of Oct 22
 -1.20 / -0.53%
Today’s Change
46.81
Today|||52-Week Range
497.00
+228.81%
Year-to-Date

Today’s Trading

Previous close225.71
Today’s open228.03
Day’s range-- - --
Volume311,154
Average volume (3 months)480,047
Market cap$4.8B
Dividend yield--
Data as of 10/22/2014

Growth & Valuation

Earnings growth (last year)+48.91%
Earnings growth (this year)-247.27%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-33.71%
P/E ratioNM
Price/Sales759.12
Price/Book53.11

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-0.48-1.36%
AKRXAkorn Inc+0.42+1.02%
GRFSGrifols SA+0.20+0.61%
OPKOPKO Health Inc-0.17-2.03%
Data as of 10/22/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$1.13
Annual revenue (last year)$1.6M
Annual profit (last year)-$67.8M
Net profit margin-4,180.52%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts